ORKA
Oruka Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$94.42+1.86%
Price as of Jul 20, 2026
ORKA ownership
Oruka Therapeutics, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
42
Net (3m)
-$313.5M
Insider trades by month Buys Sells
Feb
Mar
Apr
May
Jun
Jul
Context3-month price +34.7%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 15, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Option | 3,500 | $6.84 |
| Jul 15, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Sell | 300 | $87.25 |
| Jul 15, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Sell | 3,803 | $86.68 |
| Jul 15, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Sell | 2,497 | $85.86 |
| Jul 15, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Sell | 400 | $84.36 |
| Jul 13, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Option | 1,458 | $34.39 |
| Jul 13, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Sell | 5,656 | $84.90 |
| Jul 13, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Sell | 3,743 | $84.26 |
| Jul 13, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Sell | 300 | $83.07 |
| Jul 13, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Option | 8,541 | $12.50 |
| Jul 1, 2026 | Sandler Laura Leeofficer: Chief Operating Officer | Option | 5,000 | $7.80 |
| Jul 1, 2026 | Sandler Laura Leeofficer: Chief Operating Officer | Sell | 500 | $95.47 |
| Jul 1, 2026 | Sandler Laura Leeofficer: Chief Operating Officer | Sell | 2,263 | $94.75 |
| Jul 1, 2026 | Sandler Laura Leeofficer: Chief Operating Officer | Sell | 2,237 | $93.85 |
| Jul 1, 2026 | Fairmount Funds Management LLCdirector, 10 percent owner: | Sell | 3,553,410 | $84.43 |
| Jun 22, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Sell | 699 | $82.14 |
| Jun 22, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Sell | 888 | $80.01 |
| Jun 15, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Sell | 947 | $69.69 |
| Jun 15, 2026 | Quinlan Paul Tofficer: General Counsel | Sell | 733 | $69.69 |
| Jun 15, 2026 | Sandler Laura Leeofficer: Chief Operating Officer | Sell | 600 | $69.69 |
| Jun 15, 2026 | Klein Lawrence Ottodirector, officer: Chief Executive Officer | Sell | 1,729 | $69.69 |
| Jun 15, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Sell | 300 | $70.62 |
| Jun 15, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Sell | 5,064 | $69.42 |
| Jun 15, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Sell | 1,636 | $68.38 |
| Jun 15, 2026 | Goncalves Joanaofficer: Chief Medical Officer | Option | 3,500 | $6.84 |
| Jun 15, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Option | 8,000 | $12.50 |
| Jun 15, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Sell | 395 | $69.69 |
| Jun 15, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Sell | 3,260 | $70.34 |
| Jun 15, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Sell | 4,340 | $69.85 |
| Jun 15, 2026 | Agarwal Arjunofficer: Senior Vice President, Finance | Sell | 1,859 | $68.34 |
Source: ORKA SEC Form 4 filings, latest Jul 15, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their ORKA positions over the last 6 months (SEC Form 13F).
Increased
123
New positions
108
Reduced
53
Sold out
32
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 7.4M | May 15, 2026 |
| FMR LLC | Increased | 7.3M | Feb 17, 2026 |
| VR ADVISER, LLC | Unchanged | 4.1M | May 15, 2026 |
| VR ADVISER, LLC | Unchanged | 4.1M | Feb 17, 2026 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | Unchanged | 3.7M | May 15, 2026 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | Unchanged | 3.7M | Feb 17, 2026 |
| BLACKROCK, INC. | Increased | 3.5M | Feb 12, 2026 |
| BLACKROCK, INC. | Reduced | 3.5M | May 13, 2026 |
| VIKING GLOBAL INVESTORS LP | Unchanged | 2.7M | May 15, 2026 |
| VIKING GLOBAL INVESTORS LP | Unchanged | 2.7M | Feb 17, 2026 |
| VANGUARD GROUP INC | Increased | 2.5M | Jan 29, 2026 |
| PARADIGM BIOCAPITAL ADVISORS LP | Increased | 2.3M | May 15, 2026 |
| DEEP TRACK CAPITAL, LP | Reduced | 2.2M | Feb 13, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 2.1M | May 15, 2026 |
| RTW INVESTMENTS, LP | Increased | 2.1M | Feb 17, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.